Cabot (NYSE:CBT - Get Free Report) issued an update on its FY 2025 earnings guidance on Monday morning. The company provided EPS guidance of 7.400-7.800 for the period, compared to the consensus EPS estimate of 7.640. The company issued revenue guidance of -.
Cabot Stock Performance
NYSE CBT traded down $1.71 during trading hours on Friday, hitting $86.17. The company's stock had a trading volume of 484,546 shares, compared to its average volume of 383,378. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.08 and a quick ratio of 1.36. The company has a market cap of $4.67 billion, a P/E ratio of 12.78, a price-to-earnings-growth ratio of 0.74 and a beta of 1.19. The company's 50 day simple moving average is $93.48 and its two-hundred day simple moving average is $101.71. Cabot has a 12 month low of $77.21 and a 12 month high of $117.46.
Cabot (NYSE:CBT - Get Free Report) last released its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.74 by $0.02. Cabot had a net margin of 9.51% and a return on equity of 26.60%. As a group, sell-side analysts expect that Cabot will post 7.67 EPS for the current fiscal year.
Cabot Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Stockholders of record on Friday, February 28th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Friday, February 28th. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.00%. Cabot's dividend payout ratio (DPR) is currently 22.84%.
Cabot announced that its board has approved a share repurchase plan on Tuesday, December 3rd that permits the company to buyback 10,000,000 shares. This buyback authorization permits the specialty chemicals company to reacquire shares of its stock through open market purchases. Stock buyback plans are usually an indication that the company's board believes its shares are undervalued.
Analyst Upgrades and Downgrades
Several brokerages have issued reports on CBT. JPMorgan Chase & Co. cut Cabot from a "neutral" rating to an "underweight" rating and set a $105.00 target price on the stock. in a research report on Monday, November 11th. Mizuho cut their target price on shares of Cabot from $122.00 to $110.00 and set an "outperform" rating for the company in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Cabot has a consensus rating of "Hold" and a consensus target price of $102.00.
View Our Latest Stock Report on Cabot
Insider Buying and Selling at Cabot
In other news, EVP Jeff Ji Zhu sold 14,566 shares of the stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $113.25, for a total transaction of $1,649,599.50. Following the completion of the transaction, the executive vice president now directly owns 69,449 shares in the company, valued at approximately $7,865,099.25. This represents a 17.34 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Lisa M. Dumont sold 865 shares of the firm's stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $111.74, for a total transaction of $96,655.10. Following the completion of the transaction, the chief accounting officer now directly owns 9,742 shares of the company's stock, valued at approximately $1,088,571.08. This trade represents a 8.15 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,190 shares of company stock valued at $5,751,534 in the last three months. 3.03% of the stock is currently owned by corporate insiders.
Cabot Company Profile
(
Get Free Report)
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Articles
Before you consider Cabot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cabot wasn't on the list.
While Cabot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.